Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1989 | 12-1988 | 09-1988 | 06-1988 | 03-1988 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 10,997 | 17,374 | 6,082 | 21,858 | 11,126 |
| TOTAL | $10,997 | $17,374 | $6,082 | $21,858 | $11,126 |
| Non-Current Assets | |||||
| PPE Net | 367,243 | 357,108 | 343,692 | 325,791 | 314,908 |
| Investments And Advances | 0 | 3,143 | 481 | 3,607 | 3,190 |
| Other Non-Current Assets | 11,933 | 7,862 | 7,052 | 7,485 | 7,387 |
| TOTAL | $379,176 | $368,113 | $351,225 | $336,883 | $325,485 |
| Total Assets | $390,173 | $385,487 | $357,307 | $358,741 | $336,611 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40,828 | 58,926 | 36,604 | 32,499 | 21,815 |
| Accounts payable and accrued liabilities | 14,770 | 27,515 | 18,385 | 14,778 | 14,342 |
| Accrued Expenses | 15,878 | 3,858 | 4,750 | 10,521 | 19,053 |
| TOTAL | $76,397 | $101,375 | $76,226 | $69,123 | $61,694 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,197 | 0 | 0 | 0 | 0 |
| TOTAL | $50,577 | $49,823 | $50,598 | $49,344 | $48,703 |
| Total Liabilities | $126,974 | $151,198 | $126,824 | $118,467 | $110,397 |
| Shareholders' Equity | |||||
| Common Shares | 117,653 | 27,040 | 112,300 | 115,775 | 117,720 |
| TOTAL | $117,653 | $35,533 | $112,300 | $115,775 | $117,720 |
| Total Liabilities And Equity | $244,627 | $186,731 | $239,124 | $234,242 | $228,117 |